Douglas Lind

TMune Therapeutics, Inc. provides cancer treatment research and technology development services. It focuses on the development of T-cell therapies for the treatment of cancer and infectious diseases. The firm's proprietary cell activation technology is used and administered in patients, who are undergoing treatment for leukemia, lymphoma, and HIV. The company was founded by Louis P. Berneman in 2008 and is headquartered in Greenwich, CT.

HyperMed Imaging, Inc. engages in the manufacture of medical imaging device. It offers HyperView, is a handheld, battery operated, portable diagnostic imaging device that is use to determine oxygenation levels in superficial tissues for patients with potential circulatory compromise. The company was founded in 2006 and is headquartered in Memphis, TN.

Biomark Capital Management Co. LLC (Biomark Capital) is a private equity and venture capital firm founded in 2011 by David S. Wetherell. The firm is headquartered in Greenwich, Connecticut.

Lentigen Technology, Inc. engages in providing biotechnology services. The company was founded in 2014 and is headquartered in Gaithersburg, MD.

Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California.

Viragen, Inc. is a biotechnology company specializing in the research, development and commercialization of natural and recombinant protein-based drugs designed to treat a broad range of viral and malignant diseases. These protein-based drugs include natural human alpha interferon and monoclonal antibodies. Viragen's strategy also includes the development of Avian Transgenic Technology as a biomanufacturing platform for the large-scale, cost-effective production of therapeutic proteins. The firm is located in Plantation, FL.

Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry.